Online Only Articles

Elevated transpulmonary gradient and cardiac magnetic resonance-derived right ventricular remodeling predict poor outcomes in sickle cell disease

Cardiovascular and Pulmonary Branch, Lung and Blood Institute, Bethesda, MD, USA;Division of Cardiology, David Geffen School of Medicine at UCLA and VA Greater Los Angeles Healthcare System, CA, USA
Office of Biostatistics Research, National Heart, Lung and Blood Institute, Bethesda, MD, USA
Cardiovascular and Pulmonary Branch, Lung and Blood Institute, Bethesda, MD, USA
Sickle Cell Vascular Disease Section, Hematology Branch, Lung and Blood Institute, Bethesda, MD, USA;Howard University College of Medicine, Washington, DC, USA
Cardiovascular and Pulmonary Branch, Lung and Blood Institute, Bethesda, MD, USA;Division of Cardiovascular Medicine, University of Kentucky, Lexington, KY, USA
Sickle Cell Vascular Disease Section, Hematology Branch, Lung and Blood Institute, Bethesda, MD, USA
Sickle Cell Vascular Disease Section, Hematology Branch, Lung and Blood Institute, Bethesda, MD, USA
Sickle Cell Vascular Disease Section, Hematology Branch, Lung and Blood Institute, Bethesda, MD, USA;Division of Hematology/Oncology, Sickle Cell Center, Montefiore Medical Center, New York, NY, USA
Cardiovascular and Pulmonary Branch, Lung and Blood Institute, Bethesda, MD, USA
Cardiovascular and Pulmonary Branch, Lung and Blood Institute, Bethesda, MD, USA
Sickle Cell Vascular Disease Section, Hematology Branch, Lung and Blood Institute, Bethesda, MD, USA;Division of Hematology/Oncology and Adult Sickle Cell Center of Excellence, University of Pittsburgh, PA, USA
Vol. 101 No. 2 (2016): February, 2016 https://doi.org/10.3324/haematol.2015.125229